These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 19165233

  • 1. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease.
    Fraisl P, Aragonés J, Carmeliet P.
    Nat Rev Drug Discov; 2009 Feb; 8(2):139-52. PubMed ID: 19165233
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets.
    Miyata T, Takizawa S, van Ypersele de Strihou C.
    Am J Physiol Cell Physiol; 2011 Feb; 300(2):C226-31. PubMed ID: 20980551
    [Abstract] [Full Text] [Related]

  • 3. In vivo functions of the prolyl-4-hydroxylase domain oxygen sensors: direct route to the treatment of anaemia and the protection of ischaemic tissues.
    Katschinski DM.
    Acta Physiol (Oxf); 2009 Apr; 195(4):407-14. PubMed ID: 19183336
    [Abstract] [Full Text] [Related]

  • 4. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism.
    Aragonés J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung NH, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten SK, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P, Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris RA, Gnaiger E, Hespel P, Van Hecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P, Carmeliet P.
    Nat Genet; 2008 Feb; 40(2):170-80. PubMed ID: 18176562
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Brief anoxia preconditioning and HIF prolyl-hydroxylase inhibition enhances neuronal resistance in organotypic hippocampal slices on model of ischemic damage.
    Lushnikova I, Orlovsky M, Dosenko V, Maistrenko A, Skibo G.
    Brain Res; 2011 Apr 22; 1386():175-83. PubMed ID: 21338581
    [Abstract] [Full Text] [Related]

  • 7. Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy.
    Ratan RR, Siddiq A, Aminova L, Lange PS, Langley B, Ayoub I, Gensert J, Chavez J.
    Stroke; 2004 Nov 22; 35(11 Suppl 1):2687-9. PubMed ID: 15472113
    [Abstract] [Full Text] [Related]

  • 8. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H, Sridharan V, Wright G.
    Acta Physiol (Oxf); 2007 Jun 22; 190(2):163-9. PubMed ID: 17394573
    [Abstract] [Full Text] [Related]

  • 9. Hydroxylase inhibition reduces synaptic transmission and protects against a glutamate-induced ischemia in the CA1 region of the rat hippocampus.
    Batti L, Taylor CT, O'Connor JJ.
    Neuroscience; 2010 Jun 02; 167(4):1014-24. PubMed ID: 20298762
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Organ protection by hypoxia and hypoxia-inducible factors.
    Bernhardt WM, Warnecke C, Willam C, Tanaka T, Wiesener MS, Eckardt KU.
    Methods Enzymol; 2007 Jun 02; 435():221-45. PubMed ID: 17998057
    [Abstract] [Full Text] [Related]

  • 13. Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease.
    Cadenas S, Aragonés J, Landázuri MO.
    Cardiovasc Res; 2010 Nov 01; 88(2):219-28. PubMed ID: 20679415
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.
    Takeda K, Ichiki T, Narabayashi E, Inanaga K, Miyazaki R, Hashimoto T, Matsuura H, Ikeda J, Miyata T, Sunagawa K.
    Arterioscler Thromb Vasc Biol; 2009 Dec 01; 29(12):2132-7. PubMed ID: 19762779
    [Abstract] [Full Text] [Related]

  • 15. Prolyl-hydroxylase inhibition preserves endothelial cell function in a rat model of vascular ischemia reperfusion injury.
    Barnucz E, Veres G, Hegedűs P, Klein S, Zöller R, Radovits T, Korkmaz S, Horkay F, Merkely B, Karck M, Szabó G.
    J Pharmacol Exp Ther; 2013 Apr 01; 345(1):25-31. PubMed ID: 23388095
    [Abstract] [Full Text] [Related]

  • 16. Inflammation and Hypoxia: HIF and PHD Isoform Selectivity.
    Watts ER, Walmsley SR.
    Trends Mol Med; 2019 Jan 01; 25(1):33-46. PubMed ID: 30442494
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury.
    Schneider M, Van Geyte K, Fraisl P, Kiss J, Aragonés J, Mazzone M, Mairbäurl H, De Bock K, Jeoung NH, Mollenhauer M, Georgiadou M, Bishop T, Roncal C, Sutherland A, Jordan B, Gallez B, Weitz J, Harris RA, Maxwell P, Baes M, Ratcliffe P, Carmeliet P.
    Gastroenterology; 2010 Mar 01; 138(3):1143-54.e1-2. PubMed ID: 19818783
    [Abstract] [Full Text] [Related]

  • 19. Ischaemic and hypoxic conditioning: potential for protection of vital organs.
    Sprick JD, Mallet RT, Przyklenk K, Rickards CA.
    Exp Physiol; 2019 Mar 01; 104(3):278-294. PubMed ID: 30597638
    [Abstract] [Full Text] [Related]

  • 20. Remote renal preconditioning-induced cardioprotection: a key role of hypoxia inducible factor-prolyl 4-hydroxylases.
    Kant R, Diwan V, Jaggi AS, Singh N, Singh D.
    Mol Cell Biochem; 2008 May 01; 312(1-2):25-31. PubMed ID: 18273560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.